Every Indian IPO in one place. We score each one, and show how often we were right.
GMP is an informal figure from outside SEBI's framework. Not investment advice.
Symbiotec Pharmalab is a Mainboard issue. Our call is Not Suggested, on 50% of our checks. This is provisional while bidding is open.
7 further checks could not be judged, because the issue did not disclose enough. They count neither for nor against.